CD8A and viral infectious disease: In the present study, the MPL + poly I:C-adjuvanted iPR8 vaccine induced higher levels of CD8/CD4 TCM and TEM residing in the lungs compared with the individual adjuvanted and nonadjuvanted vaccines (Fig. 5), which conferred complete protection from severe disease outcomes upon viral infection.